Or Eisenberg
CIK: 0001721412
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRSN
NeuroSense Therapeutics Ltd.
Officer
Discretionary Trading P&L
Holdings
About Eisenberg Or
Eisenberg Or (SEC CIK 0001721412) files insider reports with the SEC as Chief Financial Officer of NeuroSense Therapeutics Ltd. (NRSN).
Signal8 holds 3 ownership filings by Eisenberg Or (1 Form 3, 2 Form 4), filed between Apr 1, 2026 and Jun 17, 2026. Those filings report 2 transactions, from Mar 26, 2026 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Eisenberg Or's filings is in HERZLIYA.
Recent filings by Eisenberg Or
Other insiders filing for NeuroSense Therapeutics Ltd. (NRSN)
- Ben-Noon Alon, Chief Executive Officer
- Russek-Blum Niva, Chief Technology Officer
- Binder Hagit, General Manager
- Pellizzari Christine A, Director
- Tracik Ferenc, Chief Medical Officer
- Claiborne Cary J, Director